| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.3 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.3 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |